RLYB (Rallybio Corp.) Net Margin

Official company branding of Rallybio (RLYB)

Rallybio Corporation develops biologics for the treatment of ultra-rare pathologies, securing monopoly revenues through patent protection. This chart on GURU.Markets includes the revenue profitability level, highlighting the flexibility of the clinical trial outsourcing model. Meanwhile, the value of 6177.40 serves as a baseline performance indicator. Business stability is guaranteed by minimal geopolitical pressure within the legal frameworks of the US and EU.

RLYB: rallybio.com Net Margin 07/04/2022 - 11/20/2026

Summary analytical data breakdowns for Rallybio (RLYB)

- market value and analyst target forecast:
- business market valuation indicators:
Comprehensive company analysis:rallybio.com, RLYB
Flagship merchandise of rallybio.com

Sales margins determine investment stability, reflecting a business's ability to convert revenue into net profit. This metric is calculated as the ratio of the final financial result to total income. The trend in aggregate sales profitability visualizes the efficiency of cost management. For Rallybio Corporation (RLYB), this indicator is specific, as revenues are generated through grants for the development of drugs for rare pathologies.

Who Rallybio Corporation competes with

HLN: Net Sales Margin|Net Return on Sales KVUE|Net Margin veronapharma.com|Net Return on Sales MENS (Jyong Biotech Corp)|Net Margin Ligand (LGND)|Net Sales Margin amneal.com (AMRX)|Net Sales Margin PRGO (perrigo.com)|Alvotech SA (ALVO) - Net Margin|Liquidia Inc. - Net Sales Margin|Net Profitability Margin Galapagos Corp (GLPG)|ANI Pharmaceuticals (ANIP) - Net Margin|Net Return on Sales MNKD|Net Margin Amphastar Pharmaceuticals, Inc.|Pacira Pharmaceuticals (PCRX) - Company Sales Margin|Net Sales Margin SPRY|TBPH - Net Margin|Aquestive Pharma - Return on Sales by Net Profit|Net Sales Margin scpharmaceuticals.com SCPH|Tectonic - Net Sales Margin|TNXP - Net Sales Margin|SXTC: Net Sales Margin|Eupraxia Pharma - Net Profit Rate|BHST (bioharvest.com) - Net Sales Margin|Net Return on Sales EXOZ (invizyne.com)|Net Sales Margin ORMP|Company Sales Margin Entera Bio|Net Sales Margin HYFT (MindWalk Holdings, Inc.)|ABVC BioPharma - Net Margin|Cumberland Corp - Net Sales Margin|QNTM - Net Sales Margin|FibroGen, Inc. (FGEN) - Net Margin|TELO: Company Net Profitability|RANI (Rani Therapeutics Inc) - Net Sales Margin|Net Margin synergychc.com SNYR|Net Sales Margin LEXX|PULM (Pulmatrix, Inc.) - Net Profit Rate|Pheton Holdings - Return on Sales by Net Profit|Net Sales Margin Aptorum Group Limited APM|LYRA: Return on Sales by Net Profit|IBO: Net Margin|TNFA: Net Sales Margin|YCBD: Company Net Profitability|Net Margin PainReform Ltd|CYTO (altamiratherapeutics.com) - Company Net Profitability|Net Sales Margin LIPO|OPTN - Net Margin|Net Margin pieris.com PIRS|Net Profit Rate PROC|PTPI - Net Margin|Qilian International Holding (QLI) - Return on Sales by Net Profit|SLRN: Net Sales Margin|Return on Sales by Net Profit TFF Pharma